Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
Crossref DOI link: https://doi.org/10.1007/s00259-017-3682-8
Published Online: 2017-03-22
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paganelli, Giovanni
Sansovini, Maddalena
Scarpi, Emanuela
Funding for this research was provided by:
partially supported by AIRC (IG10679)
License valid from 2017-03-22